1.00241

Citric acid

anhydrous powder, EMPROVE^® ESSENTIAL, Ph. Eur., BP, ChP, JP, USP, E 330, FCC

• Synonim(y): 2-Hydroxypropane-1,2,3-tricarboxylic acid, Hydroxytricarballylic acid
• Wzór liniowy: HOC(COOH)(CH₂COOH)₂
• Numer CAS: 77-92-9
• Masa cząsteczkowa: 192.12
• UNSPSC Code: 12352106
• EC Index Number: 201-069-1
• E Number: E330
• MDL number: MFCD00011669
• Beilstein/REAXYS Number: 782061

Właściwości

• Quality Segment: 500
• agency: BP, ChP, JP, Ph. Eur., USP
• reg. compliance: FCC
• vapor pressure: <0.1 hPa ( 20 °C)
• product line: EMPROVE^® ESSENTIAL
• assay: 99.5-100.5% substance (anhydrous) basis (alkalimetric)
• form: fine powder
• potency: 3000 mg/kg LD₅₀, oral (Rat)
• expl. lim.: 8 %, 65 °F
• reaction suitability: reaction type: Olefin Metathesis
• technique(s): pH adjustment: suitable
• pH: 1.7 (20 °C, 100 g/L in H₂O)
• pKa: (1) 3.13, (2) 4.76, (3) 6.4
• bp: 200 °C/1013 hPa (decomposition)
• mp: 153-159 °C (lit.)
• solubility: 1330 g/L
• density: 1.665 g/cm³ at 18 °C
• cation traces: Al: ≤0.2 ppm, As: ≤1 ppm, Hg: ≤1 ppm, Pb: ≤0.5 ppm, heavy metals (as Pb): ≤5 ppm
• application(s): liquid formulation; ophthalmics; pharmaceutical; semi-solid formulation; solid formulation; tableting
• storage temp.: 15-25°C
• SMILES string: OC(=O)CC(O)(CC(O)=O)C(O)=O
• InChI: 1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
• InChI key: KRKNYBCHXYNGOX-UHFFFAOYSA-N

Opis

General description

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge in formulation. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our Emprove^® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

Citric acid is typically used as pH adjuster, buffer agent or as antioxidant in pharmaceutical formulations. Its application range spans across different formulation types, including semi-solid dosage forms, liquid dosage forms such as solutions and solid dosage forms such as effervescent tablets or granules.
Citric acid anhydrous powder Emprove^® Essential is citric acid present in its water-free, powder form.

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS07
• Słowo ostrzegawcze: Warning
• Kody zagrożeń: H319,H335
• Ostrzeżenia: P261 - P264 - P271 - P280 - P304 + P340 + P312 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - STOT SE 3
• Narządy docelowe: Respiratory system
• Klasa składowania: 11 - Combustible Solids
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable